Alan C Farney1, Jeffrey Rogers, Robert J Stratta. 1. Department of General Surgery, Abdominal Transplant Service, Wake Forest Baptist Health, Winston-Salem, NC 27157, USA. afarney@wakehealth.edu
Abstract
PURPOSE OF REVIEW: Pancreas graft thrombosis remains one of the most common reasons for pancreas transplant loss. Patients with a history of thrombotic events should be identified and evaluated for thrombophilia to identify transplant candidates at highest risk. RECENT FINDINGS: Early after transplant, vascular thrombosis is multifactorial, but beyond 2 weeks, inflammation or acute rejection predominate as the cause of thrombosis. Most pancreas transplant centers utilize some form of anticoagulation following transplantation. Aspirin is highly recommended. Unfractionated or low-molecular-weight heparin is often administered, but some centers use heparin selectively and typically at low dose to avoid postoperative bleeding. Warfarin is less frequently given and its use should probably be limited to patients with thrombophilia. SUMMARY: Thrombectomy, either surgical or percutaneous, may salvage the pancreas graft if performed early after the occurrence of thrombosis.
PURPOSE OF REVIEW: Pancreas graft thrombosis remains one of the most common reasons for pancreas transplant loss. Patients with a history of thrombotic events should be identified and evaluated for thrombophilia to identify transplant candidates at highest risk. RECENT FINDINGS: Early after transplant, vascular thrombosis is multifactorial, but beyond 2 weeks, inflammation or acute rejection predominate as the cause of thrombosis. Most pancreas transplant centers utilize some form of anticoagulation following transplantation. Aspirin is highly recommended. Unfractionated or low-molecular-weight heparin is often administered, but some centers use heparin selectively and typically at low dose to avoid postoperative bleeding. Warfarin is less frequently given and its use should probably be limited to patients with thrombophilia. SUMMARY: Thrombectomy, either surgical or percutaneous, may salvage the pancreas graft if performed early after the occurrence of thrombosis.
Authors: Jeffrey Rogers; Alan C Farney; Giuseppe Orlando; Samy S Iskandar; William Doares; Michael D Gautreaux; Scott Kaczmorski; Amber Reeves-Daniel; Amudha Palanisamy; Robert J Stratta Journal: World J Diabetes Date: 2014-12-15
Authors: Nora Jahn; Maria Theresa Voelker; Sven Laudi; Sebastian Stehr; Stefan Schneeberger; Gerald Brandacher; Elisabeth Sucher; Sebastian Rademacher; Daniel Seehofer; Robert Sucher; Hans Michael Hau Journal: J Clin Med Date: 2022-05-03 Impact factor: 4.964
Authors: Abdul Moiz; Tariq Javed; Humberto Bohorquez; David S Bruce; Ian C Carmody; Ari J Cohen; Catherine Staffeld-Coit; Qingyang Luo; George E Loss; Jorge Garces Journal: Ochsner J Date: 2015
Authors: Martin Walter; Martin Jazra; Stylianos Kykalos; Petra Kuehn; Stefan Michalski; Thomas Klein; Andreas Wunsch; Richard Viebahn; Peter Schenker Journal: Transpl Int Date: 2014-05-24 Impact factor: 3.782
Authors: A Hakeem; J Chen; S Iype; M R Clatworthy; C J E Watson; E M Godfrey; S Upponi; K Saeb-Parsy Journal: Am J Transplant Date: 2017-09-14 Impact factor: 8.086
Authors: Agnieszka Surowiecka; Michał Frączek; Bartosz Mruk; Marta Matejak-Górska; Jerzy Walecki; Marek Durlik; Katarzyna Sklinda Journal: Med Sci Monit Date: 2020-08-23
Authors: Jeffrey Rogers; Colleen L Jay; Alan C Farney; Giuseppe Orlando; Marie L Jacobs; David Harriman; Venkat Gurram; Berjesh Sharda; Komal Gurung; Amber Reeves-Daniel; William Doares; Scott Kaczmorski; Alejandra Mena-Gutierrez; Natalia Sakhovskaya; Michael D Gautreaux; Robert J Stratta Journal: Clin Transplant Date: 2022-01-31 Impact factor: 3.456